The DOI matches its Crossref record; 24 of the 24 references it cites were found in a registry or an index.
Chronic mitochondrial energy impairment produces selective striatal degeneration and abnormal choreiform movements in primates.
Open accessAbstract
Although the gene defect responsible for Huntington disease (HD) has recently been identified, the pathogenesis of the disease remains obscure. One potential mechanism is that the gene defect may lead to an impairment of energy metabolism followed by slow excitotoxic neuronal injury. In the present study we examined whether chronic administration of 3-nitropropionic acid (3-NP), an irreversible inhibitor of succinate dehydrogenase, can replicate the neuropathologic and clinical features of HD in nonhuman primates. After 3-6 weeks of 3-NP administration, apomorphine treatment induced a significant increase in motor activity as compared with saline-treated controls. Animals showed both choreiform movements, as well as foot and limb dystonia, which are characteristic of HD. More prolonged 3-NP treatment in two additional primates resulted in spontaneous dystonia and dyskinesia accompanied by lesions in the caudate and putamen seen by magnetic resonance imaging. Histologic evaluation showed that there was a depletion of calbindin neurons, astrogliosis, sparing of NADPH-diaphorase neurons, and growth-related proliferative changes in dendrites of spiny neurons similar to changes in HD. The striosomal organization of the striatum and the nucleus accumbens were spared. These findings show that chronic administration of 3-NP to nonhuman primates can replicate many of the characteristic motor and histologic features of HD, further strengthening the possibility that a subtle impairment of energy metabolism may play a role in its pathogenesis.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Neuropathological Classification of Huntingtonʼs Disease
VONSATTEL, J.-P., MYERS, R. H., STEVENS, T. J., FERRANTE, R. J., BIRD, E. D., & RICHARDSON, E. P. (1985) · Journal of Neuropathology and Experimental Neurology · doi:10.1097/00005072-198511000-00003 · Cited by 2,227
Self-citationReplication of the neurochemical characteristics of Huntington's disease by quinolinic acid
Beal, M. F., Kowall, N. W., Ellison, D. W., Mazurek, M. F., Swartz, K. J., & Martin, J. B. (1986) · Nature · doi:10.1038/321168a0 · Cited by 1,286
Self-citationNovelli, A., Reilly, J. A., Lysko, P. G., & Henneberry, R. C. (1988) · Brain Research · doi:10.1016/0006-8993(88)90765-2 · Cited by 971
Beal, M. F. (1992) · Annals of Neurology · doi:10.1002/ana.410310202 · Cited by 961
Self-citationAlternative excitotoxic hypotheses
Albin, R. L., & Greenamyre, J. T. (1992) · Neurology · doi:10.1212/wnl.42.4.733 · Cited by 574
Chronic quinolinic acid lesions in rats closely resemble Huntington's disease
Beal, M., Ferrante, R., Swartz, K., & Kowall, N. (1991) · The Journal of Neuroscience · doi:10.1523/jneurosci.11-06-01649.1991 · Cited by 499
Self-citation3-Nitropropionic Acid - Exogenous Animal Neurotoxin and Possible Human Striatal Toxin
Ludolph, A. C., He, F., Spencer, P. S., Hammerstad, J., & Sabri, M. (1991) · Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques · doi:10.1017/s0317167100032212 · Cited by 485
Jenkins, B. G., Koroshetz, W. J., Beal, M. F., & Rosen, B. R. (1993) · Neurology · doi:10.1212/wnl.43.12.2689 · Cited by 478
Self-citationNMDA Receptor Losses in Putamen from Patients with Huntington's Disease
Young, A. B., Greenamyre, J. T., Hollingsworth, Z., Albin, R., D'Amato, C., Shoulson, I., & Penney, J. B. (1988) · Science · doi:10.1126/science.2841762 · Cited by 395
Alston, T. A., Mela, L., & Bright, H. J. (1977) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.74.9.3767 · Cited by 379
Age-dependent vulnerability of the striatum to the mitochondrial toxin 3-nitropropionic acid
Brouillet, E., Jenkins, B. G., Hyman, B. T., Ferrante, R. J., Kowall, N. W., Srivastava, R., Roy, D. S., Rosen, B. R., & Beal, M. F. (1993) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1993.tb05859.x · Cited by 367
Ferrante, R., Kowall, N., & Richardson, E. (1991) · The Journal of Neuroscience · doi:10.1523/jneurosci.11-12-03877.1991 · Cited by 306
Self-citationFerrante, R. J., Kowall, N. W., Beal, M. F., Martin, J. B., Bird, E. D., & Richardson, E. P. (1987) · Journal of Neuropathology & Experimental Neurology · doi:10.1097/00005072-198701000-00002 · Cited by 294
Self-citationBrouillet, E. P., Shinobu, L., McGarvey, U., Hochberg, F., & Beal, M. F. (1993) · Experimental Neurology · doi:10.1006/exnr.1993.1042 · Cited by 262
Self-citationSparing of acetylcholinesterase-containing striatal neurons in Huntington's disease
Ferrante, R. J., Flint Beal, M., Kowall, N. W., Richardson, E. P., & Martin, J. B. (1987) · Brain Research · doi:10.1016/0006-8993(87)90694-9 · Cited by 257
Self-citationAlbin, R. L., Young, A. B., Penney, J. B., Handelin, B., Balfour, R., Anderson, K. D., Markel, D. S., Tourtellotte, W. W., & Reiner, A. (1990) · New England Journal of Medicine · doi:10.1056/nejm199005033221807 · Cited by 243
Hamilton, B. F., & Gould, D. H. (1987) · Acta Neuropathologica · doi:10.1007/bf00691103 · Cited by 230
Hantraye, P., Riche, D., Maziere, M., & Isacson, O. (1990) · Experimental Neurology · doi:10.1016/0014-4886(90)90014-j · Cited by 175
Self-citationZeevalk, G. D., & Nicklas, W. J. (1990) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)13234-5 · Cited by 163
Mechanisms underlying initiation of excitotoxicity associated with metabolic inhibition.
Zeevalk, G. D., & Nicklas, W. J. (1991) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)24721-8 · Cited by 163
Zeevalk, G. D., & Nicklas, W. J. (1992) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1992.tb08430.x · Cited by 138
Effects of strength training on bone mineral density: hormonal and bone turnover relationships
Ryan, A. S., Treuth, M. S., Rubin, M. A., Miller, J. P., Nicklas, B. J., Landis, D. M., Pratley, R. E., Libanati, C. R., Gundberg, C. M., & Hurley, B. F. (1994) · Journal of Applied Physiology · doi:10.1152/jappl.1994.77.4.1678 · Cited by 118
Gould, D. H., & Gustine, D. L. (1982) · Neuropathology and Applied Neurobiology · doi:10.1111/j.1365-2990.1982.tb00306.x · Cited by 118
3-nitropropionic acid is an indirect excitotoxin to cultured cerebellar granule neurons
Weller, M., & Paul, S. M. (1993) · European Journal of Pharmacology Environmental Toxicology and Pharmacology · doi:10.1016/0926-6917(93)90048-u · Cited by 42
Cited by
Mitochondrial Dysfunction and Oxidative Stress in Neurodegenerative Diseases
Lin, M. T., & Beal, M. F. (2006) · Nature · doi:10.1038/nature05292 · Cited by 6,455
“The mitochondrial dysfunction observed above is likely to be pathogenically important, because 3-nitropropionic acid and malonate — mitochondrial toxins that selectively inhibit succinate dehydrogenase and complex II — induce a clinical and pathological phenotype that closely resembles H”
Self-citationCarter, R. J., Lione, L. A., Humby, T., Mangiarini, L., Mahal, A., Bates, G. P., Dunnett, S. B., & Morton, A. J. (1999) · The Journal of Neuroscience · doi:10.1523/jneurosci.19-08-03248.1999 · Cited by 947
Mitochondrial Dysfunction in Neurodegenerative Diseases
Johri, A., & Beal, M. F. (2012) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.112.192138 · Cited by 806
Self-citationMitochondrial Dysfunction Is a Primary Event in Glutamate Neurotoxicity
Schinder, A. F., Olson, E. C., Spitzer, N. C., & Montal, M. (1996) · The Journal of Neuroscience · doi:10.1523/jneurosci.16-19-06125.1996 · Cited by 769
The Role of Excitotoxicity in Neurodegenerative Disease
Doble, A. (1999) · Pharmacology & Therapeutics · doi:10.1016/s0163-7258(98)00042-4 · Cited by 723
Metadata
- Authors
- Brouillet, E., Hantraye, P., Ferrante, R. J., Dolan, R., Leroy-Willig, A., Kowall, N. W., & Beal, M. F.
- Venue
- Proceedings of the National Academy of Sciences
- Published
- 1995-07-18
- Volume
- 92
- Issue
- 15
- Pages
- 7105-7109
- ISSN
- 0027-8424 (ISSN-L)
- 1091-6490
- OpenAlex
- W1978190113
- Cited by
- 485
- References
- 24
- FWCI
- 5.84
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.